Jessica Fye
Stock Analyst at J.P. Morgan
(3.90)
# 1,855
Out of 5,090 analysts
610
Total ratings
53.3%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $276 → $300 | $215.98 | +38.90% | 35 | Oct 28, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $710 → $695 | $598.72 | +16.08% | 36 | Oct 28, 2026 | |
| BNTX BioNTech SE | Reiterated: Hold | $87 | $88.17 | -1.49% | 33 | Oct 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $86 → $87 | $58.51 | +48.69% | 18 | Oct 20, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | n/a | $85.00 | - | 17 | Oct 12, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | n/a | $251.27 | - | 52 | Oct 10, 2026 | |
| LEGN Legend Biotech | Reiterated: Hold | $35 → $33 | $21.63 | +52.57% | 14 | Oct 9, 2026 | |
| HALO Halozyme Therapeutics | Rated: Hold | $65 → $78 | $130.91 | -40.42% | 20 | Oct 8, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $425 → $445 | $370.33 | +20.16% | 15 | Oct 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Rated: Buy | $375 → $369 | $165.00 | +123.64% | 29 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $12 → $13 | $8.47 | +53.48% | 20 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $120 → $123 | $120.39 | +2.17% | 27 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $112.58 | +55.45% | 29 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $221.72 | - | 25 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 → $70 | $43.52 | +60.85% | 34 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $45.34 | - | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $530 → $560 | $558.88 | +0.20% | 22 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $10 → $13 | $12.11 | +7.35% | 11 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $6.81 | - | 14 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $30.49 | +63.99% | 15 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $88 | $55.87 | +57.51% | 4 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $65 | $38.87 | +67.22% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 → $40 | $26.29 | +52.15% | 18 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $15.93 | +107.16% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $18.94 | +53.12% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $17 | $13.15 | +29.28% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.90 | n/a | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $14 | $28.61 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $1.42 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $19 | $0.7928 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.4846 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $82.38 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 → $66 | $155.40 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $10.08 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $10.71 | n/a | 4 | Feb 8, 2018 |
Jazz Pharmaceuticals
Oct 28, 2026
Rated: Buy
Price Target: $276 → $300
Current: $215.98
Upside: +38.90%
United Therapeutics
Oct 28, 2026
Rated: Buy
Price Target: $710 → $695
Current: $598.72
Upside: +16.08%
BioNTech SE
Oct 27, 2026
Reiterated: Hold
Price Target: $87
Current: $88.17
Upside: -1.49%
BioMarin Pharmaceutical
Oct 20, 2026
Rated: Buy
Price Target: $86 → $87
Current: $58.51
Upside: +48.69%
Mirum Pharmaceuticals
Oct 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $85.00
Upside: -
Ascendis Pharma
Oct 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $251.27
Upside: -
Legend Biotech
Oct 9, 2026
Reiterated: Hold
Price Target: $35 → $33
Current: $21.63
Upside: +52.57%
Halozyme Therapeutics
Oct 8, 2026
Rated: Hold
Price Target: $65 → $78
Current: $130.91
Upside: -40.42%
BeOne Medicines AG
Oct 1, 2026
Reiterated: Buy
Price Target: $425 → $445
Current: $370.33
Upside: +20.16%
Alnylam Pharmaceuticals
Sep 30, 2026
Rated: Buy
Price Target: $375 → $369
Current: $165.00
Upside: +123.64%
Sep 30, 2026
Rated: Hold
Price Target: $12 → $13
Current: $8.47
Upside: +53.48%
Sep 28, 2026
Reiterated: Hold
Price Target: $120 → $123
Current: $120.39
Upside: +2.17%
Sep 28, 2026
Reiterated: Buy
Price Target: $175
Current: $112.58
Upside: +55.45%
Sep 28, 2026
Reiterated: Sell
Price Target: n/a
Current: $221.72
Upside: -
Sep 22, 2026
Rated: Buy
Price Target: $76 → $70
Current: $43.52
Upside: +60.85%
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $45.34
Upside: -
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $530 → $560
Current: $558.88
Upside: +0.20%
Aug 21, 2026
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $12.11
Upside: +7.35%
Aug 21, 2026
Initiated Coverage: Sell
Price Target: n/a
Current: $6.81
Upside: -
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $30.49
Upside: +63.99%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $55.87
Upside: +57.51%
Aug 21, 2026
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $38.87
Upside: +67.22%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $26.29
Upside: +52.15%
Aug 14, 2026
Rated: Buy
Price Target: $33
Current: $15.93
Upside: +107.16%
Aug 11, 2026
Reiterated: Buy
Price Target: $29
Current: $18.94
Upside: +53.12%
Jul 13, 2026
Reiterated: Hold
Price Target: $23 → $17
Current: $13.15
Upside: +29.28%
Oct 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $43.90
Upside: n/a
Jun 7, 2022
Reiterated: Hold
Price Target: $18 → $14
Current: $28.61
Upside: n/a
Apr 7, 2022
Reiterated: Hold
Price Target: $7 → $5
Current: $1.42
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $20 → $19
Current: $0.7928
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.4846
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $82.38
Upside: n/a
Apr 6, 2020
Reiterated: Hold
Price Target: $94 → $66
Current: $155.40
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $10.08
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $10.71
Upside: n/a